Financing round-up: Sarcura, Opna Bio, Turbine, RedBrick AI, Novi Health

Austria: Sarcura, a deep tech startup, has closed an oversubscribed €7m (US$7.3m) Seed Plus funding round to develop a next-generation cell therapy manufacturing platform. The round was co-led by seed investors Lansdowne Investment Company Cyprus and IST cube with participation from newly joined HCVC and tecnet equity. Besides returning seed investors Axilium Holding, NovaCapital, and Nina Capital, new European family offices with…

You must be a HMI Subscriber to view this content.

Subscribe Now »